Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia
- PMID: 37652185
- DOI: 10.1016/j.nbd.2023.106267
Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia
Abstract
Introduction: CSF Neurofilament light chain(NfL) is a promising biomarker of neurodegeneration, but its utility in discriminating between Alzheimer's disease(AD) and frontotemporal dementia(FTD) is limited.
Methods: 105 patients with clinical-biological diagnosis of mild cognitive impairment(MCI) due to AD (N = 72) or clinical diagnosis of FTD (N = 33) underwent neuropsychological assessment and CSF Aβ42/40, p-tau181, total-tau and NfL quantification. Group comparisons, correlations between continuous variables and ROC curve analysis were carried out to assess NfL role in discriminating between MCI due to AD and FTD, exploring the associations between NfL, ATN biomarkers and neuropsychological measures.
Results: NfL levels were significantly lower in the AD group, while levels of total-tau were higher. In the FTD group, significant correlations were found between NfL, p-tau181 and total-tau, and between NfL and cognitive performances. In the AD group, NfL levels were directly correlated with total-tau and p-tau181; Aβ42/40 ratio was inversely correlated with total-tau and p-tau181, but not with NfL. Moreover, p-tau181 and t-tau levels were found to be associated with episodic memory and lexical-semantic impairment. Total-tau/NfL ratio differentiated prodromal-AD from FTD with an AUC of 0.951, higher than the individual measures.
Discussion & conclusions: The results support that NfL and total-tau levels reflect distinct pathophysiological neurodegeneration mechanisms, independent and dependent of Aβ pathology, respectively, Combining them may enhance both markers reliability, their ratio showing high accuracy in distinguishing MCI due to AD from FTD. Moreover, our results revealed associations between NfL and disease severity in FTD and between tauopathy and episodic memory and lexical-semantic impairment in prodromal-AD.
Keywords: Cerebrospinal fluid biomarkers; Episodic memory; Neurodegeneration; Neurofilaments (NfL); Semantic memory; Total tau (t-tau).
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Similar articles
-
Diagnostic value of plasma p-tau181, NfL, and GFAP in a clinical setting cohort of prevalent neurodegenerative dementias.Alzheimers Res Ther. 2022 Oct 12;14(1):153. doi: 10.1186/s13195-022-01093-6. Alzheimers Res Ther. 2022. PMID: 36221099 Free PMC article.
-
Diagnostic Performance and Clinical Applicability of Blood-Based Biomarkers in a Prospective Memory Clinic Cohort.Neurology. 2023 Feb 21;100(8):e860-e873. doi: 10.1212/WNL.0000000000201597. Epub 2022 Nov 30. Neurology. 2023. PMID: 36450604 Free PMC article.
-
Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.J Alzheimers Dis. 2018;66(2):551-563. doi: 10.3233/JAD-180409. J Alzheimers Dis. 2018. PMID: 30320576
-
Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic review.J Neurol Sci. 2020 Aug 15;415:116886. doi: 10.1016/j.jns.2020.116886. Epub 2020 May 11. J Neurol Sci. 2020. PMID: 32428759
-
The role of neurofilament light chain in frontotemporal dementia: a meta-analysis.Aging Clin Exp Res. 2021 Apr;33(4):869-881. doi: 10.1007/s40520-020-01554-8. Epub 2020 Apr 18. Aging Clin Exp Res. 2021. PMID: 32306372
Cited by
-
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization.Alzheimers Dement (N Y). 2025 Feb 11;11(1):e70050. doi: 10.1002/trc2.70050. eCollection 2025 Jan-Mar. Alzheimers Dement (N Y). 2025. PMID: 39935614 Free PMC article. Review.
-
Comparison of Serum and Cerebrospinal Fluid Neurofilament Light Chain Concentrations Measured by Ella™ and Lumipulse™ in Patients with Cognitive Impairment.Diagnostics (Basel). 2024 Oct 29;14(21):2408. doi: 10.3390/diagnostics14212408. Diagnostics (Basel). 2024. PMID: 39518375 Free PMC article.
-
Radiomics feature similarity: A novel approach for characterizing brain network changes in patients with behavioral variant frontotemporal dementia.Neuroimage Clin. 2025;46:103780. doi: 10.1016/j.nicl.2025.103780. Epub 2025 Apr 5. Neuroimage Clin. 2025. PMID: 40209570 Free PMC article.
-
Serum neurofilament light protein as a biomarker in Niemann-Pick disease, type C1.Genet Med Open. 2025 Jul 7;3:103443. doi: 10.1016/j.gimo.2025.103443. eCollection 2025. Genet Med Open. 2025. PMID: 40821948 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical